Molecular targets in heart failure gene therapy: current controversies and translational perspectives-Reference-Cited by-同舟云学术

Molecular targets in heart failure gene therapy: current controversies and translational perspectives

Published:2012-04 Issue:1 Volume:1254 Page:42-50
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

Kairouz Victor,Lipskaia Larissa,Hajjar Roger J.,Chemaly Elie R.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.2012.06520.x/fullpdf

Reference62 articles.

1. Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure;Lipskaia;Expert Opin. Biol. Ther.,2010

2. Heart disease and stroke statistics-2011 update: a report from the American Heart Association;Roger;Circulation,2011

3. Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output;Gheorghiade;Discov. Med.,2011

4. Cardiac inotropes: current agents and future directions;Hasenfuss;Eur. Heart J.,2011

5. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure;Jessup;Circulation,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-378 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting AKT2;International Heart Journal;2024-05-31

2. Pharmacological and molecular mechanisms of miRNA-based therapies for targeting cardiovascular dysfunction;Biochemical Pharmacology;2024-05

3. The emerging role of miRNAs in myocardial infarction: From molecular signatures to therapeutic targets;Pathology - Research and Practice;2024-01

4. Bibliometric analysis of global research trends in adeno-associated virus vector for gene therapy (1991-2022);Frontiers in Cellular and Infection Microbiology;2023-12-08

5. Crafting a Blueprint for MicroRNA in Cardiovascular Diseases (CVDs);Current Problems in Cardiology;2023-12